Search

Your search keyword '"Alzueta Rodriguez, J"' showing total 3 results
Start Over Author "Alzueta Rodriguez, J" Topic cardiac resynchronization therapy
3 results on '"Alzueta Rodriguez, J"'

1. Sex-Specific Ventricular Arrhythmias and Mortality in Cardiac Resynchronization Therapy Recipients.

Author

Quesada A, Arteaga F, Romero-Villafranca R, Perez-Alvarez L, Martinez-Ferrer J, Alzueta-Rodriguez J, Fernández de la Concha J, Martinez JG, Viñolas X, Porres JM, Anguera I, Porro-Fernández R, Quesada-Ocete B, de la Guía-Galipienso F, Palanca V, Jimenez J, Quesada-Ocete J, and Sanchis-Gomar F

Subjects
Arrhythmias, Cardiac, Female, Humans, Male, Retrospective Studies, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Cardiac Resynchronization Therapy, Heart Failure epidemiology, Heart Failure therapy
Abstract

Objectives: The study goal was to examine whether there are sex-related differences in the incidence of ventricular arrhythmias and mortality in CRT-defibrillator (CRT-D) recipients., Background: Few studies have evaluated sex-related benefits of cardiac resynchronization therapy (CRT). Moreover, data on sex-related differences in the occurrence of ventricular tachyarrhythmias in this population are limited., Methods: A multicenter retrospective study was conducted in 460 patients (355 male subjects and 105 female subjects) from the UMBRELLA (Incidence of Arrhythmia in Spanish Population With a Medtronic Implantable Cardiac Defibrillator Implant) national registry. Patients were followed up through remote monitoring after the first implantation of a CRT-D during a median follow-up of 2.2 ± 1.0 years. Sex differences were analyzed in terms of ventricular arrhythmia-treated incidence and death during the follow-up period, with a particular focus on primary prevention patients., Results: Baseline New York Heart Association functional class was worse in women compared with that in men (67.0% of women in New York Heart Association functional class III vs. 49.7% of men; p = 0.003), whereas women had less ischemic cardiac disease (20.8% vs. 41.7%; p < 0.001). Female sex was an independent predictor of ventricular arrhythmias (hazard ratio: 0.40; 95% confidence interval: 0.19 to 0.86; p = 0.020), as well as left ventricular ejection fraction and nonischemic cardiomyopathy. Mortality in women was one-half that of men, although events were scarce and without significant differences (2.9% vs. 5.6%; p = 0.25)., Conclusions: Women with left bundle branch block and implanted CRT have a lower rate of ventricular tachyarrhythmias than men. All-cause mortality in patients is, at least, similar between female and male subjects., Competing Interests: FUNDING SUPPORT AND AUTHOR DISCLOSURES The authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)

Published
2021
Full Text
View/download PDF

2. Comments on the 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy.

Author

Fernández Lozano I, Mateas FR, Osca J, Sancho Tello MJ, García Bolao I, Martínez Ferrer J, Fidalgo Andrés ML, Rodríguez García J, Leal del Ojo J, Ripoll Vera T, Coma Sanmartín R, Cano Pérez O, Pombo Jimenez M, Medina Palomo C, Pérez Álvarez L, Hernández Madrid A, Perez Castellano N, Mont Girbau L, Mitjans AM, Arribas F, Merino Llorens JL, Pérez Villacastín J, Alzueta Rodriguez J, Carmona Salinas JR, Fernández-Ortiz A, Alonso AM, Anguita M, Cequier Á, Comín J, Diaz-Buschmann I, Fernández Lozano I, Gómez de Diego JJ, Pan M, and Worner F

Subjects
Humans, Cardiac Pacing, Artificial standards, Cardiac Resynchronization Therapy standards
Published
2014
Full Text
View/download PDF

3. BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: The ADVANCE CRT-D Trial

Author

Gasparini, M, Anselme, F, Clementy, J, Santini, M, Martínez-Ferrer, J, De Santo, T, Santi, E, Schwab, Jo, F, Ricci, R, Kloppe, A, Lunati, M, Proclemer, A, Molon, G, Delache, B, Poschmann, G, Vincenti, A, Hügl, B, Babuty, D, Martinez Ferrer, J, Alzueta Rodriguez, J, Mabo, P, Tritto, M, Bocchiardo, M, Senatore, G, Peinado, R, Tercedor, L, Davy, Jm, Elbaz, N, Glikson, M, Libero, L, Adornato, F, Mantovan, R, Pasquie, Jl, Lavergne, T, Curnis, A, Valle Tudela, V, Schäfer, J, Occhetta, E, Marzegalli, M, Cappato, R, Arenal, A, Barnay, C, Camous, Jp, Durand, P, Mermi, J, Aharon Glick SV, Solimene, F, Botto, G, Ivaldi, M, Zecchi, P, de Sousa AE, Betts, T, Bru, P, Dinanian, S, Deharo, Jc, Leenhardt, A, Sbragia, P, Da Costa, A, Geist, M, Calvi, V, Zardini, M, Orland, M, Ledesma Garcia, J, Martinez, J, Mainardis, M, Cantù, F, Leclercq, Jf, García Robles JA, Wiezcorek, M, Brambilla, R, Hennersdorf, M, Pignalberi, C, Ruiz, A, Rebellato, L, Pedrinazzi, C, Kajackas, A, Burrone, V, Martin, E, Farges, E, Silveira, J, and Pepe, M.

Subjects
Male, Tachycardia, medicine.medical_specialty, Heart Ventricles, medicine.medical_treatment, Population, Electric Countershock, Cardiac resynchronization therapy, Ventricular tachycardia, Disease-Free Survival, Electrocardiography, Internal medicine, Humans, Medicine, Single-Blind Method, Prospective Studies, education, Aged, education.field_of_study, Presyncope, medicine.diagnostic_test, business.industry, Cardiac Pacing, Artificial, medicine.disease, Defibrillators, Implantable, Survival Rate, Treatment Outcome, Anesthesia, Ventricular fibrillation, Tachycardia, Ventricular, Antitachycardia Pacing, Cardiology, Female, medicine.symptom, Cardiology and Cardiovascular Medicine, business, Follow-Up Studies
Abstract

Background This multicenter, prospective, randomized, controlled, parallel trial compares the efficacy of biventricular (BIV) versus right ventricular (RV) antitachycardia pacing (ATP) in terminating all kinds of ventricular tachycardia (VT). Methods Five hundred twenty-six patients implanted with a cardiac resynchronization therapy defibrillator (CRT-D) device were enrolled and randomized 1:1 to either BIV (266) or RV (260) ATP (single burst 8 pulse, 88% coupling interval) and were followed up for 12 months. Results During 12 months' follow-up, 1,077 ventricular episodes in 180 patients were detected and classified: 634 true VTs divided into 69 ventricular fibrillation (VF) (11%), 202 fast ventricular tachycardia (FVT) (32%), and 363 VT (57%). A comparable first ATP efficacy (BIV 65% vs RV 68%, P = .59) was observed in FVT + VT, in VT zone (BIV 62% vs RV 71%, P = .25), and in FVT zone (BIV 71% vs RV 61%, P = .34). A trend toward lower accelerations during ATP applied to FVT was observed in the BIV group (3.5% BIV vs 10.2% RV, P = .163). No syncope/presyncope occurred during ATP for FVT in the BIV group versus 4 events (3.2%) in the RV group ( P = .016). biventricular ATP was more effective in treating FVT in coronary artery disease (CAD) patients ( P = .032), whereas both modalities presented similar efficacy in patients with non-CAD etiology ( P = .549). Conclusions Antitachycardia pacing is effective in patients implanted with a CRT-D device. No significant differences in efficacy emerged between BIV- and RV-delivered ATP in the general population, whereas BIV ATP seems to present a safer profile in ischemic patients.

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results